Attitudes toward deprescribing in a middle-aged health disparities population

Date

2020

Authors

Martinez, A.I.
Spencer, J.
Moloney, M.
Badour, C.
Reeve, E.
Moga, D.C.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Research in Social and Administrative Pharmacy, 2020; 16(10):1502-1507

Statement of Responsibility

Conference Name

Abstract

Background: Patients' attitudes toward deprescribing are crucial to understand before developing interventions,but no such data exists in the medically underserved, health disparities population of rural Appalachian United States.Objective(s): Assess Appalachian women's openness to deprescribing medications and determine if polypharmacy influenced their attitudes toward deprescribing. Methods: Before and after a cognitive behavioral therapy intervention, middle-aged Appalachian women self reported medication use and completed the revised Patients’ Attitudes Toward Deprescribing Questionnaire(rPATD). Responses were described, stratified by presence of polypharmacy. Results: 30 women completed the rPATD pre- and post-intervention (mean [SD] age 55.8 [6.6] years; 96.7%white). Those with polypharmacy (n = 16) had higher burden and involvement scores (median 2.8 vs 2.0,p = 0.01; 4.9 vs 4.6, p = 0.06), and lower appropriateness scores (3.4 vs 3.9, p = 0.04). Burden, concerns about stopping, and involvement factor scores were similar before and after the intervention (p = 0.08, 0.86, and 0.41 respectively). ≥90% of participants were satisfied with their current medications yet would be willing to stop one or more. Conclusions: Middle-aged women in rural Appalachian United States are open to deprescribing; polypharmacy is associated with lower belief in the appropriateness of medications. Larger studies are needed to inform future deprescribing interventions for this and other similarly disadvantaged populations.

School/Discipline

Dissertation Note

Provenance

Description

Data source: Supplementary data, https://doi.org/10.1016/j.sapharm.2020.02.014

Access Status

Rights

Copyright 2020 Published by Elsevier Access Condition Notes: Accepted manuscript available after 1 April 2021

License

Grant ID

Call number

Persistent link to this record